Patient Safety

Ensuring the safety of medicinal products throughout their lifecycle is a fundamental obligation at MediPharm. As a GMP-certified manufacturer operating under EU pharmaceutical legislation, MediPharm maintains a rigorous pharmacovigilance system to monitor, assess, and report adverse drug reactions (ADRs) in accordance with applicable regulatory requirements, including those of the State Institute for Drug Control (ŠÚKL).

All safety-related data, including suspected adverse reactions and side effects, are systematically reviewed and evaluated. The objective is not only to communicate known risks, but also to identify previously unrecognized safety signals and ensure timely dissemination of relevant information to healthcare professionals, patients, and regulatory authorities.

If you suspect an adverse reaction associated with a medicinal product manufactured by MediPharm, please consult your attending physician. Alternatively, you may submit a report using our interactive adverse event reporting form.

📞 Report an Adverse Reaction
Suspected adverse reactions may also be reported by phone:

Phone: +421 51/4880 222

Your contribution helps strengthen the safety profile of our products and supports public health. Every report is valuable.